3D Cell Bioprinting Consortium

aid: 3dcellbioprintingconsortium
name: 3D Cell Bioprinting Consortium
description: 'The 3D Cell Bioprinting Consortium (traded on the EquityZen secondary marketplace under the symbol TDCC) is
  an alliance of laboratory-instrument and biomaterials companies formed in 2016 and publicly launched in February 2017, headquartered
  in Marlborough, Massachusetts. It describes itself as "a group of companies focused on offering the complete solution for
  tissue engineering" — coordinating bioprinter hardware, bioinks and hydrogels, cell lines and culture reagents into a single
  workflow for pre-clinical drug discovery, regenerative medicine and diagnostics. It was founded by Sid Braginsky, CEO and
  Chairman of Digilab Corp., and its named members include Digilab, Inc. (maker of the CellJet cell printer, represented by
  President and COO John Moore) and 3-D Matrix, Inc. (self-assembling peptide hydrogels, represented by Managing Director
  Marc Rioult). The consortium is a coordinating body for physical laboratory products, not a software vendor: it publishes
  no first-party website, developer portal, documentation, SDK, or machine-readable API specification, and no domain matching
  its name resolves in DNS. This profile is an independent third-party record; there is no API surface to enrich.'
url: https://raw.githubusercontent.com/api-evangelist/3dcellbioprintingconsortium/refs/heads/main/apis.yml
x-harvest-source-url: https://equityzen.com/company/3dcellbioprintingconsortium/
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: no-api-surface
x-founded: '2016'
x-headquarters: Marlborough, Massachusetts, United States
x-domain-status: none
x-domain-note: No first-party domain was found. Six name-derived candidates were probed and every one is NXDOMAIN (3dcellbioprintingconsortium.com/.org,
  3dcellbioprinting.com/.org, bioprintingconsortium.org, cellbioprintingconsortium.com). The only reachable record of the
  company is the EquityZen secondary-market listing, which is a trading venue and NOT the company's web presence, so it is
  recorded as x-harvest-source-url and is deliberately not wired as a Website pointer (roadmap#56). Note also that digilabglobal.com
  — the former host of founding member Digilab, Inc. — has been re-registered and now serves an unrelated online-gambling
  site, so it is not usable as a consortium surface either.
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  probe_state: none
  source: []
  generated: '2026-11-06'
  method: derived
specificationVersion: '0.20'
created: '2026-09-05'
modified: '2026-09-05'
tags:
- Company
- Consortium
- Bioprinting
- Tissue Engineering
- Life Sciences
- Biotechnology
- Regenerative Medicine
- Laboratory Instruments
- Biomaterials
- Drug Discovery
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-coverage:
  state: none
  reason: not-a-software-company
  detail: 'The consortium is a marketing and coordination alliance for bioprinter hardware, bioinks and cell-culture reagents
    — physical laboratory products — and it publishes no web presence of its own at all: every name-derived domain is NXDOMAIN
    and the only reachable record is its EquityZen secondary-market listing, so there is no host on which a developer program,
    spec or /.well-known surface could exist.'
  evidence:
  - url: https://equityzen.com/company/3dcellbioprintingconsortium/
    status: 200
  - url: https://3dcellbioprintingconsortium.com/
    status: 0
  - url: https://3dcellbioprinting.com/
    status: 0
  - url: https://bioprintingconsortium.org/
    status: 0
  - url: https://www.crunchbase.com/organization/3d-cell-bioprinting-consortium
    status: 403
  - url: https://api.github.com/orgs/3dcellbioprintingconsortium
    status: 404
  checked: '2026-09-05'
x-enrichment:
  date: '2026-09-05'
  status: minimal
  artifacts_added: 0
  pass: local-v3